Series B startups in Europe
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| T-Therapeutics | Cambridge | Series B | $133.0M | 2026-11-05 |
| Laza Medical | Pfaffikon | Series B | $160.0M | 2026-11-04 |
| Onego Bio | Helsinki | Series B | $28.0M | 2026-10-26 |
| Salience Labs | Oxford | Series B | $125.0M | 2026-10-14 |
| Rabot Energy | Hamburg | Series B | $56.1M | 2026-10-14 |
| Sava Technology | London | Series B | $36.0M | 2026-10-09 |
| Altilium Clean Technology | Plymouth | Series B | $1.8M | 2026-10-06 |
| WhiteLab Genomics | Paris | Series B | $26.0M | 2026-10-05 |
8 rows of the CSV in 5 of its 18 columns.
- The 1,831 series b startups in Europe have raised $37.0B in total.
- 139 of them closed their most recent round in the last 12 months, $7.9B combined.
- The largest of those rounds is Proxima Fusion's $470.1M Series B, dated July 2026.
- The most recent is T-Therapeutics' $133.0M Series B on 5 November 2026.
- Bpifrance is an investor in 49 of them, more than any other fund.
- Software is the most common sector, with 853 companies (47%).
- 9% were founded in 2020 or later; the median founding year is 2014.
- The most common team size is 11 to 50 employees (38% of companies with a recorded size).
- 7 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 1,831| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | F-Prime, Sofinnova Partners, Digitalis Ventures +2 | 51 to 100 | 2022 |
| Laza Medical | Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. | Artificial intelligence | Pfaffikon, Switzerland | Series B | $160.0M | 2026-11-04 | $196.0M | Page One Ventures, Unorthodox Ventures, The Capital Partnership | 1 to 10 | 2020 |
| Onego Bio | Onego Bio produces egg protein through fermentation as a food ingredient. | Biotech | Helsinki, Finland | Series B | $28.0M | 2026-10-26 | $100.6M | European Innovation Council, Business Finland, Tesi +2 | 11 to 50 | 2022 |
| Salience Labs | Salience Labs develops optical networking technology using silicon photonics, electronics, and machine learning. | Artificial intelligence | Oxford, United Kingdom | Series B | $125.0M | 2026-10-14 | $166.5M | Oxford Science Enterprises, Cambridge Innovation Capital, Deeptech Labs +2 | 51 to 100 | 2021 |
| Rabot Energy | Rabot Energy supplies green electricity with flexible and smart tariffs for homes and electric vehicles. | Energy | Hamburg, Germany | Series B | $56.1M | 2026-10-14 | $79.7M | HTGF (High-Tech Gruenderfonds), HV Capital, Yabeo +1 | 101 to 250 | 2021 |
| Sava Technology | Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. | Biotech | London, United Kingdom | Series B | $36.0M | 2026-10-09 | $62.8M | SOSV, Balderton Capital, Social Starts +1 | 101 to 250 | 2016 |
| Altilium Clean Technology | Altilium Clean Technology decarbonizes the supply of electric vehicles to support the shift from fossil fuels to zero-carbon energy. | Energy | Plymouth, United Kingdom | Series B | $1.8M | 2026-10-06 | $45.8M | Faraday Battery Challenge | 11 to 50 | 2020 |
| WhiteLab Genomics | WhiteLab Genomics builds digital tools that help gene and cell therapy companies develop drugs faster and cheaper. | Artificial intelligence | Paris, France | Series B | $26.0M | 2026-10-05 | $36.5M | Y Combinator, Omnes Capital | 11 to 50 | 2019 |
| Wealthcome | Wealthcome offers wealth management tools for tracking expenses, reducing fees, and analyzing investment performance. | Artificial intelligence | Bordeaux, France | Series B | $17.1M | 2026-09-24 | $25.7M | Alter Equity 3P, TechnoStart | 51 to 100 | 2022 |
| Incepto Medical | Incepto Medical develops artificial intelligence software for medical imaging. | Artificial intelligence | Paris, France | Series B | $16.0M | 2026-09-22 | $49.2M | Bpifrance, AVP, Karista +2 | 51 to 100 | 2018 |
| Ryft | Ryft offers a payment platform that lets businesses accept payments across all platforms. | Commerce | London, United Kingdom | Series B | $26.8M | 2026-09-17 | $36.1M | Pareto Holdings, SFC Capital, Innovate UK | 51 to 100 | 2019 |
| Hackuity | Hackuity provides a cybersecurity platform for identifying, prioritizing, and managing vulnerabilities. | Artificial intelligence | Lyon, France | Series B | $18.5M | 2026-09-16 | $36.7M | Bright Pixel Capital | 51 to 100 | 2018 |
| Kaiko | Kaiko provides market data, analytics, and indices for investors, regulators, and financial firms. | Fintech | Paris, France | Series B | $110.0M | 2026-09-14 | $192.5M | Eight Roads Ventures, Point Nine, Anthemis +2 | 51 to 100 | 2014 |
| Tandem Health | Tandem Health develops AI tools for clinical documentation, coding, decision support, and follow-up in healthcare. | Artificial intelligence | Stockholm, Sweden | Series B | $100.0M | 2026-09-14 | $159.7M | Northzone, Amino Collective | 101 to 250 | 2023 |
| Xapien | Xapien provides AI-powered due diligence and risk intelligence on people, organizations, and business relationships. | Artificial intelligence | London, United Kingdom | Series B | $55.9M | 2026-09-10 | $73.8M | YFM Equity Partners, Kinled Holding, Deeptech Labs +1 | 51 to 100 | 2018 |
| CloudNC | CloudNC develops software that lets factories autonomously manufacture precision parts. | Artificial intelligence | London, United Kingdom | Series B | $20.0M | 2026-09-08 | $97.6M | Innovate UK, IQT, XTX Ventures | 101 to 250 | 2015 |
| iPronics | iPronics develops programmable optical networking systems for AI data centers and high-performance computing. | Artificial intelligence | Valencia, Spain | Series B | $125.0M | 2026-09-02 | $164.2M | Amadeus Capital Partners, Criteria Venture Tech | 101 to 250 | 2019 |
| NovaGo Therapeutics | NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. | Biotech | Schlieren, Switzerland | Series B | $29.7M | 2026-08-31 | $39.7M | Kinled Holding, Pureos Bioventures | 1 to 10 | 2015 |
| Triver | Triver provides invoice financing and working capital solutions to help small businesses access cash from unpaid invoices. | Artificial intelligence | London, United Kingdom | Series B | $10.9M | 2026-08-26 | $131.8M | FJ Labs, Pareto Holdings, Axeleo Capital | 11 to 50 | 2023 |
| Pixelgen Technologies | Pixelgen Technologies develops technologies for biomedical research and diagnostics. | Biotech | Stockholm, Sweden | Series B | $15.5M | 2026-08-20 | $43.5M | Industrifonden, Navigare Ventures, Colibri Ventures +1 | 11 to 50 | 2020 |
| Computomics | Computomics applies artificial intelligence to genomics data to advance agricultural solutions. | Artificial intelligence | Tübingen, Germany | Series B | $7.3M | 2026-08-18 | $10.0M | HTGF (High-Tech Gruenderfonds), VentureOut, European Innovation Council +2 | 11 to 50 | 2012 |
| SweGaN | SweGaN provides GaN-on-SiC epiwafers for RF component manufacturers. | Hardware | Linköping, Sweden | Series B | $14.0M | 2026-08-17 | $39.7M | Almi Invest, Atlantic Bridge, Navigare Ventures | 11 to 50 | 2014 |
| Vaderis Therapeutics | Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. | Biotech | Basel, Switzerland | Series B | $152.0M | 2026-08-11 | $170.6M | Medicxi | 11 to 50 | 2019 |
| Finster AI | Finster AI provides financial research tools for asset management and investment banking professionals. | Artificial intelligence | London, United Kingdom | Series B | $10.0M | 2026-08-10 | $16.8M | Hoxton Ventures | 11 to 50 | 2023 |
| Omilia | Omilia provides AI-powered customer service automation through voice, chat, authentication, and workforce solutions. | Artificial intelligence | Limassol, Cyprus | Series B | $67.0M | 2026-08-06 | $87.0M | Grafton Capital | 501 to 1,000 | 2002 |
| Mironid | Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. | Biotech | Glasgow, United Kingdom | Series B | $45.9M | 2026-08-05 | $90.6M | Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 | 11 to 50 | 2014 |
| Qureight | Qureight develops imaging technologies and analytics software for biopharmaceutical companies. | Artificial intelligence | Cambridge, United Kingdom | Series B | $20.0M | 2026-07-29 | $31.2M | Ascension, Playfair Capital, XTX Ventures | 11 to 50 | 2018 |
| Greyparrot | Greyparrot develops AI software that helps recycling and waste management companies recover resources more effectively. | Artificial intelligence | London, United Kingdom | Series B | $27.0M | 2026-07-28 | $57.9M | Plug and Play, Creative Destruction Lab, Speedinvest +2 | 101 to 250 | 2019 |
| METR | METR develops software for energy management, smart metering, and building optimization in real estate. | Software | Berlin, Germany | Series B | $12.0M | 2026-07-27 | $18.5M | Next Big Thing, Mujinzo Labs, The BraWo Capital Group | 11 to 50 | 2016 |
| Risk Ledger | Risk Ledger helps organizations manage security risks across their vendor and supply chain networks. | Cybersecurity | London, United Kingdom | Series B | $32.5M | 2026-07-15 | $44.9M | Seedcamp, Firstminute Capital, Lifeline Ventures +2 | 11 to 50 | 2018 |
Table 1. Series B startups in Europe: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 1,831.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CuspAI | CuspAI enables structured search for discovering physical materials. | Artificial intelligence | Cambridge, United Kingdom | Series B | $450.0M | 2026-06-17 | $580.0M | FJ Labs, Lightspeed Venture Partners, LocalGlobe +2 | 51 to 100 | 2024 |
| 2 | Black Forest Labs | Black Forest Labs develops generative deep learning models that create and modify visual content. | Artificial intelligence | Freiburg Im Breisgau, Germany | Series B | $300.0M | 2025-12-01 | $450.2M | Andreessen Horowitz, General Catalyst, Mätch VC | 11 to 50 | 2024 |
| 3 | Morpho Labs | Morpho Labs provides decentralized lending and borrowing services for cryptocurrency users. | Fintech | Paris, France | Series B | $175.0M | 2026-06-09 | $244.3M | Hack VC, Robot Ventures, a16z crypto +2 | 51 to 100 | 2021 |
| 4 | Windward Bio | Windward Bio develops monoclonal antibodies for advanced immunological diseases. | Biotech | Basel, Switzerland | Series B | $165.0M | 2026-05-04 | $365.0M | Qiming Venture Partners, OrbiMed, Novo Holdings +2 | 11 to 50 | 2024 |
| 5 | Laza Medical | Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. | Artificial intelligence | Pfaffikon, Switzerland | Series B | $160.0M | 2026-11-04 | $196.0M | Page One Ventures, Unorthodox Ventures, The Capital Partnership | 1 to 10 | 2020 |
| 6 | Vaderis Therapeutics | Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. | Biotech | Basel, Switzerland | Series B | $152.0M | 2026-08-11 | $170.6M | Medicxi | 11 to 50 | 2019 |
| 7 | T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | F-Prime, Sofinnova Partners, Digitalis Ventures +2 | 51 to 100 | 2022 |
| 8 | Salience Labs | Salience Labs develops optical networking technology using silicon photonics, electronics, and machine learning. | Artificial intelligence | Oxford, United Kingdom | Series B | $125.0M | 2026-10-14 | $166.5M | Oxford Science Enterprises, Cambridge Innovation Capital, Deeptech Labs +2 | 51 to 100 | 2021 |
| 9 | iPronics | iPronics develops programmable optical networking systems for AI data centers and high-performance computing. | Artificial intelligence | Valencia, Spain | Series B | $125.0M | 2026-09-02 | $164.2M | Amadeus Capital Partners, Criteria Venture Tech | 101 to 250 | 2019 |
| 10 | Kaiko | Kaiko provides market data, analytics, and indices for investors, regulators, and financial firms. | Fintech | Paris, France | Series B | $110.0M | 2026-09-14 | $192.5M | Eight Roads Ventures, Point Nine, Anthemis +2 | 51 to 100 | 2014 |
Table 2. Series B startups in Europe: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Bpifrance | Government investment office | Maisons-alfort, France | 49 | 3% | 3 | Incepto Medical, Alice & Bob, Standing Ovation |
| 2 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 41 | 2% | 2 | Rabot Energy, Computomics |
| 3 | Index Ventures | Venture capital firm | San Francisco, United States | 28 | 2% | 1 | Evervault |
| 4 | Seedcamp | Micro VC fund | London, United Kingdom | 19 | 1% | 3 | Risk Ledger, TILT, Dust |
| 5 | European Innovation Council | Startup accelerator | Brussels, Belgium | 18 | 1% | 5 | Onego Bio, Computomics, Alice & Bob |
| 6 | Balderton Capital | Venture capital firm | London, United Kingdom | 18 | 1% | 3 | Sava Technology, TILT, Qargo |
| 7 | Speedinvest | Venture capital firm | Vienna, Austria | 18 | 1% | 2 | Greyparrot, Sona |
| 8 | Accel | Venture capital firm | Palo Alto, United States | 18 | 1% | ||
| 9 | Octopus Ventures | Venture capital firm | London, United Kingdom | 18 | 1% | ||
| 10 | FJ Labs | Micro VC fund | New York, United States | 17 | 1% | 2 | Triver, CuspAI |
| 11 | Kima Ventures | Micro VC fund | Paris, France | 16 | 1% | 2 | Cryptio, Naboo |
| 12 | HV Capital | Venture capital firm | Munich, Germany | 15 | 1% | 2 | Rabot Energy, SPREAD AI |
| 13 | Innovate UK | Entrepreneurship program | Swindon, United Kingdom | 15 | 1% | 2 | Ryft, CloudNC |
| 14 | Techstars | Startup accelerator | New York, United States | 15 | 1% | 3 | Covatic, EcoG, Overstory |
| 15 | Seventure Partners | Venture capital firm | Paris, France | 15 | 1% | 1 | Standing Ovation |
Table 3. Series B startups in Europe: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 853 | 47% | $19.2B |
| Health care | 347 | 19% | $10.3B |
| Hardware | 296 | 16% | $5.5B |
| Biotech | 249 | 14% | $7.5B |
| Fintech | 245 | 13% | $5.4B |
| Commerce | 239 | 13% | $1.6B |
| Artificial intelligence | 230 | 13% | $10.1B |
| Energy | 95 | 5% | $3.0B |
| Cybersecurity | 88 | 5% | $1.4B |
| Education | 37 | 2% | $811.2M |
Table 4. Series B startups in Europe by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 1,831 | 100% | $15.0M |
Table 5. Series B startups in Europe by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| United Kingdom | 499 | 27% |
| France | 345 | 19% |
| Germany | 315 | 17% |
| Switzerland | 124 | 7% |
| The Netherlands | 101 | 6% |
| Spain | 75 | 4% |
| Sweden | 51 | 3% |
| Ireland | 47 | 3% |
| Italy | 47 | 3% |
| Belgium | 47 | 3% |
| Finland | 35 | 2% |
| Denmark | 26 | 1% |
Table 6. Series B startups in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Series B startups in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 3 | 2% | $405.0M |
| October 2026 | 9 | 6% | $452.9M |
| September 2026 | 15 | 11% | $996.3M |
| August 2026 | 12 | 9% | $697.1M |
| July 2026 | 18 | 13% | $1.1B |
| June 2026 | 14 | 10% | $911.4M |
| May 2026 | 14 | 10% | $775.3M |
| April 2026 | 11 | 8% | $477.0M |
| March 2026 | 14 | 10% | $529.7M |
| February 2026 | 10 | 7% | $348.4M |
| January 2026 | 9 | 6% | $364.2M |
| December 2025 | 5 | 4% | $669.7M |
| November 2025 | 5 | 4% | $125.7M |
Table 8. Series B startups in Europe: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 129 | 7% | $7.1B |
| 2025 | 156 | 9% | $5.5B |
| 2024 | 140 | 8% | $4.2B |
| 2023 | 138 | 8% | $3.3B |
| 2022 | 199 | 11% | $6.8B |
| 2021 | 168 | 9% | $5.1B |
Table 9. Series B startups in Europe by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 19 | 1% |
| 2020 to 2022 | 139 | 8% |
| 2015 to 2019 | 639 | 35% |
| 2010 to 2014 | 500 | 27% |
| Before 2010 | 528 | 29% |
Table 10. Series B startups in Europe by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 181 | 10% |
| 11 to 50 | 680 | 38% |
| 51 to 100 | 425 | 24% |
| 101 to 250 | 399 | 22% |
| 251 to 500 | 67 | 4% |
| 501 to 1,000 | 28 | 2% |
| 1,001 to 5,000 | 15 | 1% |
| 5,001 to 10,000 | 3 | 0% |
| 10,001 or more | 8 | 0% |
Table 11. Series B startups in Europe by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when its most recent funding round is Series B and its headquarters is in Europe. On 16 November 2026 that is 1,831 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 1,831 rows: 239 have no round amount, 0 no city and 781 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many series b startups in Europe are on the list?
- 1,831, in the file dated 16 November 2026. 139 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 1,831 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.